Search the website

Search results

4651 results

Sort by

List item

Agenda - CVMP agenda of the 15-17 June 2021 meeting (PDF/288.17 KB) (new)

Draft
First published: 15/06/2021
EMA/308464/2021
List item

Monthly report on application procedures, guidelines and related documents for veterinary medicines: April 2021 (PDF/260.45 KB) (new)

Adopted
First published: 10/06/2021
EMA/195931/2021
List item

EU VICH adverse event report implementation guide (PDF/680.16 KB) (new)

Draft: consultation open
First published: 04/06/2021
Consultations dates: from 04/06/2021 to 04/08/2021
EMA/186368/2021
List item

Monthly report on application procedures, guidelines and related documents for veterinary medicines: March 2021 (PDF/257.84 KB) (new)

Adopted
First published: 04/06/2021
EMA/195931/2021
List item

Veterinary Medicines Regulation highlights - Issue 5 (PDF/1.02 MB) (new)

First published: 31/05/2021
Issue 5
List item

Reflection paper on methods found suitable within the EU for demonstrating freedom from extraneous agents of the seeds used for the production of immunological veterinary medicinal products (PDF/341.91 KB) (new)

Draft: consultation open
First published: 25/05/2021
Consultations dates: from 21/05/2021 to 23/07/2021
EMA/CVMP/IWP/251741/2015 Rev. 1
List item

Paromomycin (tissues and eggs of all food producing species): European public MRL assessment report (EPMAR) - CVMP (PDF/273.86 KB) (new)

Adopted
First published: 25/05/2021
EMA/CVMP/56180/2018
List item

News: Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 10-12 May 2021 (new)

CVMP, Last updated: 17/05/2021
List item

CVMP summary of positive opinion for Bonqat (PDF/137 KB) (new)

Adopted
First published: 17/05/2021
EMA/CVMP/241883/2021
List item

Enteroporc Coli : EPAR - Procedural steps taken and scientific information after the authorisation (PDF/103 KB)

First published: 12/05/2021
List item

Agenda - CVMP agenda of the 10-12 May 2021 meeting (PDF/238.03 KB)

Draft
First published: 10/05/2021
EMA/CVMP/242543/2021
List item

OvuGel : EPAR - Public assessment report (PDF/379.24 KB)

Adopted
First published: 07/05/2021
EMA/518898/2020
List item

OvuGel : EPAR - All authorised presentations (PDF/72.88 KB)

First published: 07/05/2021
Bulgarian
(PDF/89.77 KB)

Croatian
(PDF/84.06 KB)

Czech
(PDF/82.07 KB)

Danish
(PDF/73.54 KB)

Dutch
(PDF/73.88 KB)

Estonian
(PDF/81.85 KB)

Finnish
(PDF/93.31 KB)

French
(PDF/74.32 KB)

German
(PDF/75.92 KB)

Greek
(PDF/80.37 KB)

Hungarian
(PDF/83.48 KB)

Icelandic
(PDF/75.17 KB)

Italian
(PDF/73.02 KB)

Latvian
(PDF/90.57 KB)

Lithuanian
(PDF/91.39 KB)

Maltese
(PDF/91.83 KB)

Norwegian
(PDF/74.05 KB)

Polish
(PDF/90.76 KB)

Portuguese
(PDF/73.83 KB)

Romanian
(PDF/81.57 KB)

Slovak
(PDF/90.09 KB)

Slovenian
(PDF/85.93 KB)

Spanish
(PDF/72.87 KB)

Swedish
(PDF/75.29 KB)
List item

OvuGel : EPAR - Product information (PDF/686.36 KB)

First published: 07/05/2021
Bulgarian
(PDF/761.49 KB)

Croatian
(PDF/725.72 KB)

Czech
(PDF/759.85 KB)

Danish
(PDF/314.02 KB)

Dutch
(PDF/706.16 KB)

Estonian
(PDF/667.27 KB)

Finnish
(PDF/656.43 KB)

French
(PDF/677.88 KB)

German
(PDF/685.19 KB)

Greek
(PDF/761.85 KB)

Hungarian
(PDF/759.92 KB)

Icelandic
(PDF/676.6 KB)

Italian
(PDF/301.29 KB)

Latvian
(PDF/380.53 KB)

Lithuanian
(PDF/762.72 KB)

Maltese
(PDF/762.46 KB)

Norwegian
(PDF/686.86 KB)

Polish
(PDF/744.94 KB)

Portuguese
(PDF/678.74 KB)

Romanian
(PDF/761.49 KB)

Slovak
(PDF/771.3 KB)

Slovenian
(PDF/757.44 KB)

Spanish
(PDF/668.56 KB)

Swedish
(PDF/671.86 KB)
List item

OvuGel : EPAR - Medicine overview (DOCX/117.34 KB)

First published: 07/05/2021
EMA/518868/2020
Bulgarian
(PDF/157.25 KB)

Croatian
(PDF/156.87 KB)

Czech
(PDF/153.95 KB)

Danish
(PDF/132.48 KB)

Dutch
(PDF/132.54 KB)

Estonian
(PDF/131.07 KB)

Finnish
(PDF/131.11 KB)

French
(PDF/134.12 KB)

German
(PDF/136.69 KB)

Greek
(PDF/155.1 KB)

Hungarian
(PDF/156.7 KB)

Italian
(PDF/131.92 KB)

Latvian
(PDF/169.82 KB)

Lithuanian
(PDF/154.6 KB)

Maltese
(PDF/157.25 KB)

Polish
(PDF/157.08 KB)

Portuguese
(PDF/134.92 KB)

Romanian
(PDF/151.06 KB)

Slovak
(PDF/155.61 KB)

Slovenian
(PDF/153.54 KB)

Spanish
(PDF/134.46 KB)

Swedish
(PDF/132.28 KB)
List item

Librela : EPAR - Public assessment report (PDF/445.19 KB)

Adopted
First published: 06/05/2021
EMA/518235/2020
List item

Librela : EPAR - Medicine overview (PDF/132.74 KB)

First published: 06/05/2021
EMA/518254/2020
Bulgarian
(PDF/157.67 KB)

Croatian
(PDF/154.19 KB)

Czech
(PDF/154.82 KB)

Danish
(PDF/131.94 KB)

Dutch
(PDF/131.82 KB)

Estonian
(PDF/131.71 KB)

Finnish
(PDF/130.43 KB)

French
(PDF/132.84 KB)

German
(PDF/134.98 KB)

Greek
(PDF/157.93 KB)

Hungarian
(PDF/152.63 KB)

Italian
(PDF/130.74 KB)

Latvian
(PDF/163.85 KB)

Lithuanian
(PDF/154.02 KB)

Maltese
(PDF/154.99 KB)

Polish
(PDF/154.6 KB)

Portuguese
(PDF/134.06 KB)

Romanian
(PDF/151.69 KB)

Slovak
(PDF/155.06 KB)

Slovenian
(PDF/150.6 KB)

Spanish
(PDF/132.23 KB)

Swedish
(PDF/131.76 KB)
List item

Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Bupivacaine (PDF/107.95 KB)

Adopted
First published: 06/05/2021
EMA/CVMP/70565/2020
List item

Minutes of the CVMP meeting of 16-18 March 2021 (PDF/340.16 KB)

Adopted
First published: 03/05/2021
EMA/CVMP/212369/2021
List item

Bupivacaine (porcine species): Summary report - Committee for Veterinary Medicinal Products (PDF/346.87 KB)

Adopted
First published: 28/04/2021
EMA/CVMP/89867/2020
List item

Concept paper for the revision of the guideline on the summary of product characteristics for anthelmintics (PDF/217.67 KB)

Draft: consultation closed
First published: 26/04/2021
Consultations dates: from 22/04/2021 to 31/05/2021
EMA/CVMP/EWP/165592/2021
List item

NexGard Combo : EPAR - Public assessment report (PDF/569.09 KB)

Adopted
First published: 20/04/2021
EMA/640861/2020
List item

Opinion of the CVMP on the establishment of maximum residue limits : Imidacloprid (PDF/135.12 KB)

Adopted
First published: 19/04/2021
EMA/CVMP/446874/2020
List item

Imidacloprid (fin fish): Summary report - Committee for Veterinary Medicinal Products (PDF/284.94 KB)

Adopted
First published: 19/04/2021
EMA/CVMP/223046/2021
List item

Prevexxion RN : EPAR - Public assessment report (PDF/363.62 KB)

Adopted
First published: 16/04/2021
EMA/321289/2020

4651 results

Agenda - CVMP agenda of the 15-17 June 2021 meeting (PDF/288.17 KB) (new)

Monthly report on application procedures, guidelines and related documents for veterinary medicines: April 2021 (PDF/260.45 KB) (new)

EU VICH adverse event report implementation guide (PDF/680.16 KB) (new)

Monthly report on application procedures, guidelines and related documents for veterinary medicines: March 2021 (PDF/257.84 KB) (new)

Veterinary Medicines Regulation highlights - Issue 5 (PDF/1.02 MB) (new)

Reflection paper on methods found suitable within the EU for demonstrating freedom from extraneous agents of the seeds used for the production of immunological veterinary medicinal products (PDF/341.91 KB) (new)

Paromomycin (tissues and eggs of all food producing species): European public MRL assessment report (EPMAR) - CVMP (PDF/273.86 KB) (new)

News: Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 10-12 May 2021 (new)

CVMP summary of positive opinion for Bonqat (PDF/137 KB) (new)

Enteroporc Coli : EPAR - Procedural steps taken and scientific information after the authorisation (PDF/103 KB)

Agenda - CVMP agenda of the 10-12 May 2021 meeting (PDF/238.03 KB)

OvuGel : EPAR - Public assessment report (PDF/379.24 KB)

OvuGel : EPAR - All authorised presentations (PDF/72.88 KB)

OvuGel : EPAR - Product information (PDF/686.36 KB)

OvuGel : EPAR - Medicine overview (DOCX/117.34 KB)

Librela : EPAR - Public assessment report (PDF/445.19 KB)

Librela : EPAR - Medicine overview (PDF/132.74 KB)

Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Bupivacaine (PDF/107.95 KB)

Minutes of the CVMP meeting of 16-18 March 2021 (PDF/340.16 KB)

Bupivacaine (porcine species): Summary report - Committee for Veterinary Medicinal Products (PDF/346.87 KB)

Concept paper for the revision of the guideline on the summary of product characteristics for anthelmintics (PDF/217.67 KB)

NexGard Combo : EPAR - Public assessment report (PDF/569.09 KB)

Opinion of the CVMP on the establishment of maximum residue limits : Imidacloprid (PDF/135.12 KB)

Imidacloprid (fin fish): Summary report - Committee for Veterinary Medicinal Products (PDF/284.94 KB)

Prevexxion RN : EPAR - Public assessment report (PDF/363.62 KB)